Highlights PreveCeutical Medical Inc.

Equities

CA74141E1043

Market Closed - Canadian Securities Exchange Other stock markets 11:36:48 2024-06-27 am EDT			5-day change	1st Jan Change
0.025 ^CAD	-.--%		-.--%	-.--%

Jul. 05	PreveCeutical Medical Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Jun. 28	PreveCeutical Medical Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

PreveCeutical Medical Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	Jul. 05	CI
PreveCeutical Medical Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Jun. 28	CI
PreveCeutical Medical Inc. Initiates Preparation of Preclinical Study for Its Diseases & Obtains Proof-Of-Concept Dual Gene Therapy Program	Dec. 04	CI
PreveCeutical Medical Prepares For Proof of Concept Preclinical Study For Diabetes, Obesity Dual Gene Therapy Program	Dec. 04	MT
PreveCeutical Medical Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 20	CI
PreveCeutical & Endosane Announce Update on Intranasal CBD Application	23-09-18	MT
PreveCeutical Medical Inc. and Endosane Pharmaceuticals GmbH Announces Innovative Preclinical Approaches to Assess Brain Availability of CBD and Pharmacologically Relevant Doses Following Intranasal CBD Application	23-09-18	CI
PreveCeutical Medical Inc. Showcases Dynamic Evolution in AI Strategy	23-09-12	CI
PreveCeutical Medical Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-24	CI
PrevCeutical Medical Provides Update	23-07-24	MT
PreveCeutical Medical Inc. Files Cyclic Peptides and Uses Thereof in EU and Australia	23-07-24	CI
PreveCeutical Medical Inc. Files Two Family Patents of Sol-Gel Cannabinoid Formulation and Antiviral Use & Cyclic Peptides and Uses Thereof	23-06-28	CI
Preveceutical Medical Inc. Furthering the Progress of Its Patent Family Directed to Sol-Gel	23-05-30	CI
PreveCeutical Medical Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-29	CI
PreveCeutical Medical Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-30	CI
PreveCeutical Medical Inc. Launches Clinical Artificial Intelligence Division	23-04-24	CI
PreveCeutical Medical Inc. Signs Sol-Gel License Agreement with Its Subsidiary PreveCeutical Pty Ltd	23-01-09	CI
PreveCeutical Medical Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-25	CI
Preveceutical Medical Inc. Announces Appointment of Kathleen Rotika to Board of Directors	22-10-20	CI
PreveCeutical Medical Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-24	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights PreveCeutical Medical Inc.

Equities

PREV

CA74141E1043

Highlights

Filters